| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1111576868 |
| P356 | DOI | 10.1186/S13023-019-0994-8 |
| P932 | PMC publication ID | 6341540 |
| P698 | PubMed publication ID | 30665444 |
| P50 | author | Tyler B Johnson | Q59819663 |
| Jill M Weimer | Q89194542 | ||
| P2093 | author name string | Alexander D Kloth | |
| Jacob T Cain | |||
| Katherine A White | |||
| Samantha S Davis | |||
| McKayla J Poppens | |||
| Rachel Laufmann | |||
| P2860 | cites work | Etiologies underlying sex differences in Autism Spectrum Disorders | Q22251432 |
| Females experience a more severe disease course in Batten disease | Q24602745 | ||
| Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse | Q24633059 | ||
| Spectrum of mutations in the Batten disease gene, CLN3 | Q24678552 | ||
| Sex differences in Parkinson's disease | Q27025107 | ||
| A murine model of variant late infantile ceroid lipofuscinosis recapitulates behavioral and pathological phenotypes of human disease | Q27303003 | ||
| Isolation of a novel gene underlying Batten disease, CLN3. The International Batten Disease Consortium | Q28288921 | ||
| Retinal oxidation, apoptosis and age- and sex-differences in the mnd mutant mouse, a model of neuronal ceroid lipofuscinosis | Q28511611 | ||
| Neuronal ceroid lipofuscinosis (nclf), a new disorder of the mouse linked to chromosome 9 | Q28591663 | ||
| Estrogen actions in the central nervous system | Q33658556 | ||
| Sex differences in cognitive impairment and Alzheimer's disease | Q33864547 | ||
| Immunosuppression alters disease severity in juvenile Batten disease mice | Q34142898 | ||
| Novel mutations in the CLN6 gene causing a variant late infantile neuronal ceroid lipofuscinosis. | Q34188178 | ||
| Spectrum of CLN6 mutations in variant late infantile neuronal ceroid lipofuscinosis | Q34207198 | ||
| Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses. | Q34336077 | ||
| Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses | Q34427575 | ||
| Sex bias in neuroscience and biomedical research | Q34433270 | ||
| The neuronal ceroid-lipofuscinoses | Q35045618 | ||
| Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis | Q35088229 | ||
| Finding the most appropriate mouse model of juvenile CLN3 (Batten) disease for therapeutic studies: the importance of genetic background and gender | Q35237718 | ||
| Current state of clinical and morphological features in human NCL. | Q35681059 | ||
| Sex differences in microglial colonization of the developing rat brain | Q35812893 | ||
| Electroclinical spectrum of the neuronal ceroid lipofuscinoses associated with CLN6 mutations | Q35904791 | ||
| Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications | Q36102771 | ||
| Sex Differences in the Study of Neurological Illnesses | Q36453477 | ||
| Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells | Q36560125 | ||
| Gonadal hormones and the control of reactive gliosis. | Q37991787 | ||
| NCL disease mechanisms | Q38109408 | ||
| Sex differences in attention Deficit Hyperactivity Disorder: candidate genetic and endocrine mechanisms. | Q38200373 | ||
| Inflammatory Response in the CNS: Friend or Foe? | Q38790379 | ||
| Sex differences in microglial phagocytosis in the neonatal hippocampus | Q38877499 | ||
| The importance of studying sex differences in disease: The example of multiple sclerosis | Q39015338 | ||
| The neuronal ceroid-lipofuscinoses (Batten disease): comparative aspects | Q40538599 | ||
| Selective estrogen receptor modulators decrease reactive astrogliosis in the injured brain: effects of aging and prolonged depletion of ovarian hormones | Q43268433 | ||
| Blindness in South Hampshire sheep: a neuronal ceroidlipofuscinosis | Q44423488 | ||
| Cell cycle arrest in Batten disease lymphoblast cells | Q44738253 | ||
| Sex differences in the phagocytic and migratory activity of microglia and their impairment by palmitic acid | Q47579436 | ||
| Testosterone decreases reactive astroglia and reactive microglia after brain injury in male rats: role of its metabolites, oestradiol and dihydrotestosterone. | Q48140133 | ||
| Gender differences in risk factors for transition from mild cognitive impairment to Alzheimer's disease: A CREDOS study. | Q53355173 | ||
| Neuronal ceroid lipofuscinoses | Q56566989 | ||
| Variant late infantile ceroid lipofuscinoses associated with novel mutations in CLN6 | Q60232624 | ||
| Short-Term Administration of Mycophenolate Is Well-Tolerated in CLN3 Disease (Juvenile Neuronal Ceroid Lipofuscinosis) | Q64044847 | ||
| Gonadal hormones down-regulate reactive gliosis and astrocyte proliferation after a penetrating brain injury | Q72785086 | ||
| Cln3(Deltaex7/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth | Q78358538 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 19 | |
| P577 | publication date | 2019-01-21 | |
| P1433 | published in | Orphanet Journal of Rare Diseases | Q15756117 |
| P1476 | title | Tracking sex-dependent differences in a mouse model of CLN6-Batten disease | |
| P478 | volume | 14 |
| Q96816294 | A tailored Cln3Q352X mouse model for testing therapeutic interventions in CLN3 Batten disease | cites work | P2860 |
Search more.